This should raise alarms The staggeringly high discontinuation rates of GLP-1 RA should raise alarms for clinicians, policy makers, and public health experts, said Khan, associate professor of medicine (cardiology) and preventive medicine (epidemiology) at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician
Semaglutide should not be used with another semaglutide-containing product or another GLP-1 agonist
New findings from the Fralin Biomedical Research Institute at VTC, published this month in Scientific Reports, suggest that GLP-1 agonists slow the rate at which alcohol enters the bloodstream
Both tirzepatide and semaglutide are used for weight loss
Statements Author contributions JC: Methodology, Writing original draft, Conceptualization, Writing review & editing, Validation, Formal analysis